BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 33662628)

  • 1. Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients.
    Zhao Z; Zhang KN; Wang Q; Li G; Zeng F; Zhang Y; Wu F; Chai R; Wang Z; Zhang C; Zhang W; Bao Z; Jiang T
    Genomics Proteomics Bioinformatics; 2021 Feb; 19(1):1-12. PubMed ID: 33662628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GliomaDB: A Web Server for Integrating Glioma Omics Data and Interactive Analysis.
    Yang Y; Sui Y; Xie B; Qu H; Fang X
    Genomics Proteomics Bioinformatics; 2019 Aug; 17(4):465-471. PubMed ID: 31811943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of a nine-gene signature in glioma patients based on mRNA expression profiling.
    Bao ZS; Li MY; Wang JY; Zhang CB; Wang HJ; Yan W; Liu YW; Zhang W; Chen L; Jiang T
    CNS Neurosci Ther; 2014 Feb; 20(2):112-8. PubMed ID: 24279471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioma-BioDP: database for visualization of molecular profiles to improve prognosis of brain cancer.
    Deng X; Das S; Kaur H; Wilson E; Camphausen K; Shankavaram U
    BMC Med Genomics; 2023 Jul; 16(1):168. PubMed ID: 37454191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAB38 confers a poor prognosis, associated with malignant progression and subtype preference in glioma.
    Wang H; Jiang C
    Oncol Rep; 2013 Nov; 30(5):2350-6. PubMed ID: 24026199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma.
    Wang Z; Wang Z; Zhang C; Liu X; Li G; Liu S; Sun L; Liang J; Hu H; Liu Y; Zhang W; Jiang T
    Cancer Sci; 2018 Sep; 109(9):2697-2705. PubMed ID: 30027617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatic Profiling Identifies a Glucose-Related Risk Signature for the Malignancy of Glioma and the Survival of Patients.
    Zhao S; Cai J; Li J; Bao G; Li D; Li Y; Zhai X; Jiang C; Fan L
    Mol Neurobiol; 2017 Dec; 54(10):8203-8210. PubMed ID: 27900679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rab27a was identified as a prognostic biomaker by mRNA profiling, correlated with malignant progression and subtype preference in gliomas.
    Wang H; Zhao Y; Zhang C; Li M; Jiang C; Li Y
    PLoS One; 2014; 9(2):e89782. PubMed ID: 24587032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of genes associated with cancer prognosis in glioma:
    Lv J; Ren F; Lv Z; Chang Z; Li W; He Y; Chen L
    J Bioinform Comput Biol; 2021 Jun; 19(3):2140004. PubMed ID: 33971799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma.
    Zhang JH; Hou R; Pan Y; Gao Y; Yang Y; Tian W; Zhu YB
    J Cell Mol Med; 2020 Jul; 24(13):7504-7514. PubMed ID: 32412186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
    Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A
    J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated analysis of the genomic and transcriptional profile of high-grade gliomas in different age groups.
    Yang P; Liu Q; Tao R; Shan X; Huang R; Wang K; Wang J
    Clin Immunol; 2021 May; 226():108719. PubMed ID: 33819578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGFR3, as a receptor tyrosine kinase, is associated with differentiated biological functions and improved survival of glioma patients.
    Wang Z; Zhang C; Sun L; Liang J; Liu X; Li G; Yao K; Zhang W; Jiang T
    Oncotarget; 2016 Dec; 7(51):84587-84593. PubMed ID: 27829236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BMP4, a strong better prognosis predictor, has a subtype preference and cell development association in gliomas.
    Bao Z; Zhang C; Yan W; Liu Y; Li M; Zhang W; Jiang T
    J Transl Med; 2013 Apr; 11():100. PubMed ID: 23590708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration and analysis of genome-scale data from gliomas.
    Riddick G; Fine HA
    Nat Rev Neurol; 2011 Jul; 7(8):439-50. PubMed ID: 21727940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiogenomics of lower-grade glioma: algorithmically-assessed tumor shape is associated with tumor genomic subtypes and patient outcomes in a multi-institutional study with The Cancer Genome Atlas data.
    Mazurowski MA; Clark K; Czarnek NM; Shamsesfandabadi P; Peters KB; Saha A
    J Neurooncol; 2017 May; 133(1):27-35. PubMed ID: 28470431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of hub genes related to prognosis in glioma.
    Zhang D; Zhao J; Han C; Liu X; Liu J; Yang H
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32406502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEGF10, a Glioma Survival-Associated Molecular Signature, Predicts IDH Mutation Status.
    Li G; Wang Z; Zhang C; Liu X; Yang F; Sun L; Liang J; Hu H; Liu Y; You G; Bao Z; Zhang W; Wang Z; Jiang T
    Dis Markers; 2018; 2018():5975216. PubMed ID: 29887919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Na/H exchanger 1 (SLC9A1) emerges as a marker for tumorigenesis and prognosis in gliomas.
    Guan X; Luo L; Begum G; Kohanbash G; Song Q; Rao A; Amankulor N; Sun B; Sun D; Jia W
    J Exp Clin Cancer Res; 2018 Oct; 37(1):255. PubMed ID: 30333031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Immune-Related lncRNA Signature to Predict Survival In Glioma Patients.
    Xia P; Li Q; Wu G; Huang Y
    Cell Mol Neurobiol; 2021 Mar; 41(2):365-375. PubMed ID: 32410107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.